

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.72791766 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.68979301 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.49386806 |
| 4 | glutamate secretion (GO:0014047) | 5.27553926 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.21708400 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.12670326 |
| 7 | vocalization behavior (GO:0071625) | 5.00587762 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.99448229 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.84660395 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.68345276 |
| 11 | neuronal action potential propagation (GO:0019227) | 4.61971638 |
| 12 | neuron cell-cell adhesion (GO:0007158) | 4.56531723 |
| 13 | layer formation in cerebral cortex (GO:0021819) | 4.45758667 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.41474558 |
| 15 | protein localization to synapse (GO:0035418) | 4.39799467 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.39111457 |
| 17 | exploration behavior (GO:0035640) | 4.30227944 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.27604982 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.13862697 |
| 20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.13604424 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.08270468 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.06295576 |
| 23 | dendritic spine morphogenesis (GO:0060997) | 3.96158182 |
| 24 | regulation of synapse structural plasticity (GO:0051823) | 3.84959318 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.81921275 |
| 26 | neuron recognition (GO:0008038) | 3.81546413 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 3.81134695 |
| 28 | proline transport (GO:0015824) | 3.81060016 |
| 29 | cellular potassium ion homeostasis (GO:0030007) | 3.72127573 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.70457395 |
| 31 | gamma-aminobutyric acid transport (GO:0015812) | 3.70446467 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 3.66745647 |
| 33 | activation of protein kinase A activity (GO:0034199) | 3.55013008 |
| 34 | neurotransmitter transport (GO:0006836) | 3.51325334 |
| 35 | axonal fasciculation (GO:0007413) | 3.50693023 |
| 36 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.48097006 |
| 37 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.46694975 |
| 38 | long-term memory (GO:0007616) | 3.44415865 |
| 39 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.43408156 |
| 40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.39438136 |
| 41 | synaptic vesicle endocytosis (GO:0048488) | 3.35379420 |
| 42 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.35159435 |
| 43 | regulation of synaptic plasticity (GO:0048167) | 3.32462447 |
| 44 | positive regulation of synapse maturation (GO:0090129) | 3.32408110 |
| 45 | regulation of vesicle fusion (GO:0031338) | 3.31301314 |
| 46 | vesicle transport along microtubule (GO:0047496) | 3.31171393 |
| 47 | sodium ion export (GO:0071436) | 3.29242427 |
| 48 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.28411744 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.27729263 |
| 50 | positive regulation of membrane potential (GO:0045838) | 3.26599320 |
| 51 | regulation of neurotransmitter secretion (GO:0046928) | 3.25524548 |
| 52 | transmission of nerve impulse (GO:0019226) | 3.25301630 |
| 53 | establishment of mitochondrion localization (GO:0051654) | 3.24908807 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.24842211 |
| 55 | dendrite morphogenesis (GO:0048813) | 3.24231933 |
| 56 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.23475245 |
| 57 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.22672096 |
| 58 | long-term synaptic potentiation (GO:0060291) | 3.21355420 |
| 59 | regulation of neurotransmitter levels (GO:0001505) | 3.20658677 |
| 60 | mating behavior (GO:0007617) | 3.17997463 |
| 61 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.13772150 |
| 62 | amino acid import (GO:0043090) | 3.13004739 |
| 63 | innervation (GO:0060384) | 3.10910211 |
| 64 | cell migration in hindbrain (GO:0021535) | 3.09520166 |
| 65 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.08801708 |
| 66 | neuromuscular process controlling balance (GO:0050885) | 3.08593480 |
| 67 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.07610510 |
| 68 | presynaptic membrane assembly (GO:0097105) | 3.06654110 |
| 69 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.03982933 |
| 70 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.03031615 |
| 71 | postsynaptic membrane organization (GO:0001941) | 3.00722886 |
| 72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.99912906 |
| 73 | regulation of neurotransmitter transport (GO:0051588) | 2.98862115 |
| 74 | synapse assembly (GO:0007416) | 2.97882504 |
| 75 | cell communication involved in cardiac conduction (GO:0086065) | 2.95664862 |
| 76 | dendritic spine organization (GO:0097061) | 2.93906037 |
| 77 | * organelle transport along microtubule (GO:0072384) | 2.92343309 |
| 78 | auditory behavior (GO:0031223) | 2.92313788 |
| 79 | cerebellar granule cell differentiation (GO:0021707) | 2.92022515 |
| 80 | regulation of dendritic spine development (GO:0060998) | 2.91030817 |
| 81 | presynaptic membrane organization (GO:0097090) | 2.90777419 |
| 82 | negative regulation of microtubule polymerization (GO:0031115) | 2.90538536 |
| 83 | cell communication by electrical coupling (GO:0010644) | 2.89558273 |
| 84 | clathrin coat assembly (GO:0048268) | 2.88504741 |
| 85 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.87484590 |
| 86 | detection of calcium ion (GO:0005513) | 2.87071226 |
| 87 | membrane depolarization (GO:0051899) | 2.84715054 |
| 88 | membrane depolarization during action potential (GO:0086010) | 2.84016711 |
| 89 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.83876635 |
| 90 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.83262451 |
| 91 | nucleobase catabolic process (GO:0046113) | 2.83257253 |
| 92 | learning (GO:0007612) | 2.83022569 |
| 93 | synaptic transmission (GO:0007268) | 2.82995941 |
| 94 | synapse organization (GO:0050808) | 2.82617606 |
| 95 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.81354839 |
| 96 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.81155985 |
| 97 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.80277944 |
| 98 | neuromuscular process controlling posture (GO:0050884) | 2.79922660 |
| 99 | synaptic vesicle transport (GO:0048489) | 2.79819915 |
| 100 | establishment of synaptic vesicle localization (GO:0097480) | 2.79819915 |
| 101 | regulation of synaptic transmission (GO:0050804) | 2.79771658 |
| 102 | neuronal ion channel clustering (GO:0045161) | 2.78949596 |
| 103 | social behavior (GO:0035176) | 2.78249250 |
| 104 | intraspecies interaction between organisms (GO:0051703) | 2.78249250 |
| 105 | positive regulation of dendritic spine development (GO:0060999) | 2.78221355 |
| 106 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.77599325 |
| 107 | glycine transport (GO:0015816) | 2.76169517 |
| 108 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.75047578 |
| 109 | response to histamine (GO:0034776) | 2.74931700 |
| 110 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.74508255 |
| 111 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.74195546 |
| 112 | behavioral defense response (GO:0002209) | 2.73418813 |
| 113 | behavioral fear response (GO:0001662) | 2.73418813 |
| 114 | establishment of vesicle localization (GO:0051650) | 2.73258011 |
| 115 | L-amino acid import (GO:0043092) | 2.71718564 |
| 116 | potassium ion homeostasis (GO:0055075) | 2.67999660 |
| 117 | neurotransmitter uptake (GO:0001504) | 2.67250284 |
| 118 | acidic amino acid transport (GO:0015800) | 2.63312732 |
| 119 | nerve growth factor signaling pathway (GO:0038180) | 2.62992380 |
| 120 | cellular sodium ion homeostasis (GO:0006883) | 2.61773598 |
| 121 | response to auditory stimulus (GO:0010996) | 2.61053942 |
| 122 | vesicle docking (GO:0048278) | 2.54926965 |
| 123 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.53382903 |
| 124 | negative regulation of neurotransmitter transport (GO:0051589) | 2.52519713 |
| 125 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.50638044 |
| 126 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.48875282 |
| 127 | mitochondrion transport along microtubule (GO:0047497) | 2.48875282 |
| 128 | COPI coating of Golgi vesicle (GO:0048205) | 2.42958948 |
| 129 | Golgi transport vesicle coating (GO:0048200) | 2.42958948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.94716733 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.34679205 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11786760 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.03072710 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02995170 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70310340 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70310340 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60089209 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57774679 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.57706849 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51946835 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48476301 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48163126 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47761427 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42544361 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.34249788 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23570178 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.21266340 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18686580 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14346143 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13919126 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08540461 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.96517789 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.96409749 |
| 25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.92549381 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91639932 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85247707 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.83652797 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72910561 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71675570 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71400952 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71049567 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64200610 |
| 34 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.58410276 |
| 35 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.58410276 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57456608 |
| 37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.53318181 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52963634 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52941134 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50347925 |
| 41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.49244363 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48401994 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45045360 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.43375237 |
| 45 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.42417921 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40507839 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36955333 |
| 48 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36618646 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35823481 |
| 50 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34611467 |
| 51 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34307704 |
| 52 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31778613 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31495620 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30712212 |
| 55 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.30578568 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30180610 |
| 57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29448942 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28603425 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27348186 |
| 60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26940068 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26193607 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25386210 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25262321 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25031422 |
| 65 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.24363453 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23085709 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22439629 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20541583 |
| 69 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19452116 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18661074 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18360284 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16810708 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16739651 |
| 74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16547233 |
| 75 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15112314 |
| 76 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14308023 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14021538 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13837473 |
| 79 | * AR_19668381_ChIP-Seq_PC3_Human | 1.13605480 |
| 80 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13148234 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.12785549 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11219833 |
| 83 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10677727 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10464371 |
| 85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09964402 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09198027 |
| 87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08717740 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07934728 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07357856 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06742016 |
| 91 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05744815 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04779900 |
| 93 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04074571 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03647857 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03373726 |
| 96 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01740843 |
| 97 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.01559459 |
| 98 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00834214 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00522967 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00362853 |
| 101 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99538355 |
| 102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99211260 |
| 103 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.98666004 |
| 104 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97981264 |
| 105 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.97976942 |
| 106 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97871027 |
| 107 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97863477 |
| 108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97804874 |
| 109 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.97441344 |
| 110 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97276647 |
| 111 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97229242 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97000600 |
| 113 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96766453 |
| 114 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96550845 |
| 115 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.95790082 |
| 116 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95616557 |
| 117 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94590497 |
| 118 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93741073 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 0.93726301 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92903632 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92876398 |
| 122 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92658714 |
| 123 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92047801 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91235817 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85582859 |
| 126 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84402587 |
| 127 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82685805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.17558188 |
| 2 | MP0003880_abnormal_central_pattern | 4.79522547 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.07100963 |
| 4 | MP0004270_analgesia | 4.00496235 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.23314122 |
| 6 | MP0009745_abnormal_behavioral_response | 3.22857709 |
| 7 | MP0002064_seizures | 3.08344067 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.05726776 |
| 9 | MP0009046_muscle_twitch | 2.93686818 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.80224488 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.67184349 |
| 12 | MP0002272_abnormal_nervous_system | 2.54195778 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.50396517 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.49010870 |
| 15 | MP0001486_abnormal_startle_reflex | 2.42540546 |
| 16 | MP0002736_abnormal_nociception_after | 2.34615658 |
| 17 | MP0003329_amyloid_beta_deposits | 2.29975585 |
| 18 | MP0002733_abnormal_thermal_nociception | 2.26135398 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.20560720 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.11482452 |
| 21 | MP0004858_abnormal_nervous_system | 2.06709653 |
| 22 | MP0001970_abnormal_pain_threshold | 2.06370072 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.05405955 |
| 24 | MP0000778_abnormal_nervous_system | 2.02345231 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.00847209 |
| 26 | MP0002184_abnormal_innervation | 1.99255085 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.98612792 |
| 28 | MP0002822_catalepsy | 1.89609708 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.77443967 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.76277414 |
| 31 | MP0008569_lethality_at_weaning | 1.76095109 |
| 32 | MP0001984_abnormal_olfaction | 1.75484606 |
| 33 | MP0004924_abnormal_behavior | 1.72679261 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.72679261 |
| 35 | MP0000955_abnormal_spinal_cord | 1.70276353 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.69845366 |
| 37 | MP0002882_abnormal_neuron_morphology | 1.47184399 |
| 38 | MP0004885_abnormal_endolymph | 1.44520914 |
| 39 | MP0002066_abnormal_motor_capabilities/c | 1.42870169 |
| 40 | MP0003879_abnormal_hair_cell | 1.37244012 |
| 41 | MP0001905_abnormal_dopamine_level | 1.32168901 |
| 42 | MP0001529_abnormal_vocalization | 1.31799908 |
| 43 | MP0003633_abnormal_nervous_system | 1.29411698 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.25926035 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.23004737 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.20590385 |
| 47 | MP0004142_abnormal_muscle_tone | 1.19814183 |
| 48 | MP0003122_maternal_imprinting | 1.14752365 |
| 49 | MP0003631_nervous_system_phenotype | 1.14679161 |
| 50 | MP0001188_hyperpigmentation | 1.14277078 |
| 51 | MP0002152_abnormal_brain_morphology | 1.13473008 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.12982279 |
| 53 | MP0005275_abnormal_skin_tensile | 1.11730861 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.08669391 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.07632701 |
| 56 | MP0003787_abnormal_imprinting | 1.04696262 |
| 57 | MP0000604_amyloidosis | 1.03193165 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.02074905 |
| 59 | MP0003634_abnormal_glial_cell | 1.01600990 |
| 60 | MP0002796_impaired_skin_barrier | 1.01498863 |
| 61 | MP0002229_neurodegeneration | 1.01119308 |
| 62 | MP0000751_myopathy | 1.00821998 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.98834866 |
| 64 | MP0000920_abnormal_myelination | 0.98766868 |
| 65 | MP0004742_abnormal_vestibular_system | 0.98094445 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 0.97012370 |
| 67 | MP0000579_abnormal_nail_morphology | 0.95184478 |
| 68 | MP0003632_abnormal_nervous_system | 0.91523602 |
| 69 | MP0005623_abnormal_meninges_morphology | 0.91377904 |
| 70 | MP0002069_abnormal_eating/drinking_beha | 0.86819512 |
| 71 | MP0003121_genomic_imprinting | 0.85682784 |
| 72 | MP0001177_atelectasis | 0.85154033 |
| 73 | MP0003283_abnormal_digestive_organ | 0.85138994 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 0.83253251 |
| 75 | MP0008874_decreased_physiological_sensi | 0.82423492 |
| 76 | MP0008872_abnormal_physiological_respon | 0.82389754 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.81928444 |
| 78 | MP0002752_abnormal_somatic_nervous | 0.81742011 |
| 79 | MP0004484_altered_response_of | 0.81588448 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.81397535 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.80955005 |
| 82 | MP0004085_abnormal_heartbeat | 0.80326029 |
| 83 | MP0005535_abnormal_body_temperature | 0.79000667 |
| 84 | MP0004272_abnormal_basement_membrane | 0.77561339 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.76272748 |
| 86 | MP0003690_abnormal_glial_cell | 0.75269398 |
| 87 | MP0001879_abnormal_lymphatic_vessel | 0.74947876 |
| 88 | MP0005499_abnormal_olfactory_system | 0.73932740 |
| 89 | MP0005394_taste/olfaction_phenotype | 0.73932740 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.72440400 |
| 91 | MP0005248_abnormal_Harderian_gland | 0.72065434 |
| 92 | MP0001485_abnormal_pinna_reflex | 0.71856772 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.71676811 |
| 94 | MP0000569_abnormal_digit_pigmentation | 0.71003976 |
| 95 | MP0002896_abnormal_bone_mineralization | 0.70992668 |
| 96 | MP0000631_abnormal_neuroendocrine_gland | 0.70951540 |
| 97 | MP0005187_abnormal_penis_morphology | 0.69975274 |
| 98 | MP0002090_abnormal_vision | 0.69331724 |
| 99 | MP0009384_cardiac_valve_regurgitation | 0.68607184 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.66048697 |
| 101 | MP0004233_abnormal_muscle_weight | 0.65705489 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64539137 |
| 103 | MP0003861_abnormal_nervous_system | 0.63924248 |
| 104 | MP0003123_paternal_imprinting | 0.63473949 |
| 105 | MP0001664_abnormal_digestion | 0.61899944 |
| 106 | MP0003385_abnormal_body_wall | 0.61786451 |
| 107 | MP0000462_abnormal_digestive_system | 0.61080927 |
| 108 | MP0003075_altered_response_to | 0.60831621 |
| 109 | MP0001943_abnormal_respiration | 0.60794362 |
| 110 | MP0000747_muscle_weakness | 0.57947378 |
| 111 | MP0003279_aneurysm | 0.57411425 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.57183057 |
| 113 | MP0004043_abnormal_pH_regulation | 0.57145137 |
| 114 | MP0005620_abnormal_muscle_contractility | 0.56238251 |
| 115 | MP0002081_perinatal_lethality | 0.56037724 |
| 116 | MP0001542_abnormal_bone_strength | 0.54557927 |
| 117 | MP0001348_abnormal_lacrimal_gland | 0.54382765 |
| 118 | MP0010769_abnormal_survival | 0.51542368 |
| 119 | MP0002082_postnatal_lethality | 0.50591685 |
| 120 | MP0010770_preweaning_lethality | 0.50591685 |
| 121 | MP0005409_darkened_coat_color | 0.50560402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.12654789 |
| 2 | Myokymia (HP:0002411) | 6.09990675 |
| 3 | Focal seizures (HP:0007359) | 5.43917666 |
| 4 | Visual hallucinations (HP:0002367) | 5.24762750 |
| 5 | Atonic seizures (HP:0010819) | 4.73673665 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.51475166 |
| 7 | Absence seizures (HP:0002121) | 4.16692416 |
| 8 | Febrile seizures (HP:0002373) | 4.01711440 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 3.99004046 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.96582211 |
| 11 | Action tremor (HP:0002345) | 3.82299085 |
| 12 | Dialeptic seizures (HP:0011146) | 3.78038101 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.73606540 |
| 14 | Ankle clonus (HP:0011448) | 3.39896851 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.39146692 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.35602059 |
| 17 | Insidious onset (HP:0003587) | 3.32066579 |
| 18 | Termporal pattern (HP:0011008) | 3.32066579 |
| 19 | Papillary thyroid carcinoma (HP:0002895) | 3.22327028 |
| 20 | Broad-based gait (HP:0002136) | 3.15757715 |
| 21 | Papilledema (HP:0001085) | 3.13098908 |
| 22 | Mutism (HP:0002300) | 3.08627243 |
| 23 | Hyperventilation (HP:0002883) | 3.04820053 |
| 24 | Amblyopia (HP:0000646) | 3.04641201 |
| 25 | Poor eye contact (HP:0000817) | 3.01146690 |
| 26 | Depression (HP:0000716) | 3.00009576 |
| 27 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.92286417 |
| 28 | Progressive inability to walk (HP:0002505) | 2.91617952 |
| 29 | Truncal ataxia (HP:0002078) | 2.90997810 |
| 30 | Dysmetria (HP:0001310) | 2.90547945 |
| 31 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.90526374 |
| 32 | Dysdiadochokinesis (HP:0002075) | 2.88653976 |
| 33 | Split foot (HP:0001839) | 2.85290470 |
| 34 | Abnormality of the corticospinal tract (HP:0002492) | 2.83702223 |
| 35 | Gaze-evoked nystagmus (HP:0000640) | 2.82202609 |
| 36 | Anxiety (HP:0000739) | 2.81751082 |
| 37 | Urinary urgency (HP:0000012) | 2.80583079 |
| 38 | Impaired social interactions (HP:0000735) | 2.80054813 |
| 39 | Abnormal social behavior (HP:0012433) | 2.80054813 |
| 40 | Pheochromocytoma (HP:0002666) | 2.77620250 |
| 41 | Excessive salivation (HP:0003781) | 2.75404741 |
| 42 | Drooling (HP:0002307) | 2.75404741 |
| 43 | Hammertoe (HP:0001765) | 2.74759485 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.72094226 |
| 45 | Limb dystonia (HP:0002451) | 2.67270075 |
| 46 | Spastic gait (HP:0002064) | 2.63057942 |
| 47 | Postural instability (HP:0002172) | 2.61835674 |
| 48 | Megalencephaly (HP:0001355) | 2.57661640 |
| 49 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.57281589 |
| 50 | Aplasia of the phalanges of the hand (HP:0009802) | 2.57281589 |
| 51 | Aplasia involving bones of the extremities (HP:0009825) | 2.57281589 |
| 52 | Genetic anticipation (HP:0003743) | 2.54275846 |
| 53 | Scanning speech (HP:0002168) | 2.53978052 |
| 54 | Tetraparesis (HP:0002273) | 2.46674443 |
| 55 | Epileptiform EEG discharges (HP:0011182) | 2.45861117 |
| 56 | Intention tremor (HP:0002080) | 2.45002588 |
| 57 | EEG with generalized epileptiform discharges (HP:0011198) | 2.40725892 |
| 58 | Absent speech (HP:0001344) | 2.39985431 |
| 59 | Hemiparesis (HP:0001269) | 2.39191431 |
| 60 | Amyotrophic lateral sclerosis (HP:0007354) | 2.37937289 |
| 61 | Neuroendocrine neoplasm (HP:0100634) | 2.36881111 |
| 62 | Agitation (HP:0000713) | 2.36741785 |
| 63 | Hand muscle atrophy (HP:0009130) | 2.34901081 |
| 64 | Diplopia (HP:0000651) | 2.32949259 |
| 65 | Abnormality of binocular vision (HP:0011514) | 2.32949259 |
| 66 | Torticollis (HP:0000473) | 2.29110842 |
| 67 | Hypsarrhythmia (HP:0002521) | 2.28531331 |
| 68 | Abnormality of the lower motor neuron (HP:0002366) | 2.27597718 |
| 69 | Lower limb muscle weakness (HP:0007340) | 2.25236533 |
| 70 | Bradykinesia (HP:0002067) | 2.24566256 |
| 71 | Inability to walk (HP:0002540) | 2.22426237 |
| 72 | Fetal akinesia sequence (HP:0001989) | 2.21162071 |
| 73 | Impaired smooth pursuit (HP:0007772) | 2.17647440 |
| 74 | Cortical dysplasia (HP:0002539) | 2.17588909 |
| 75 | Atrioventricular block (HP:0001678) | 2.17464187 |
| 76 | Generalized myoclonic seizures (HP:0002123) | 2.17379109 |
| 77 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.16224760 |
| 78 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.16224760 |
| 79 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.16205785 |
| 80 | Stereotypic behavior (HP:0000733) | 2.15323692 |
| 81 | Thyroid carcinoma (HP:0002890) | 2.13495068 |
| 82 | Arterial tortuosity (HP:0005116) | 2.11750152 |
| 83 | Focal dystonia (HP:0004373) | 2.11450052 |
| 84 | Polyphagia (HP:0002591) | 2.11038424 |
| 85 | Retinal dysplasia (HP:0007973) | 2.08118447 |
| 86 | Akinesia (HP:0002304) | 2.05540257 |
| 87 | Distal upper limb amyotrophy (HP:0007149) | 2.03407068 |
| 88 | Upper limb amyotrophy (HP:0009129) | 2.03407068 |
| 89 | Rapidly progressive (HP:0003678) | 2.01477551 |
| 90 | Vascular tortuosity (HP:0004948) | 1.97814097 |
| 91 | Status epilepticus (HP:0002133) | 1.96739561 |
| 92 | Ventricular fibrillation (HP:0001663) | 1.96037971 |
| 93 | Delusions (HP:0000746) | 1.94112608 |
| 94 | Heterochromia iridis (HP:0001100) | 1.91638074 |
| 95 | Gait ataxia (HP:0002066) | 1.90082536 |
| 96 | Craniofacial dystonia (HP:0012179) | 1.89192974 |
| 97 | Lower limb asymmetry (HP:0100559) | 1.89040259 |
| 98 | Impaired vibratory sensation (HP:0002495) | 1.88036862 |
| 99 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.87476509 |
| 100 | Lower limb amyotrophy (HP:0007210) | 1.86808674 |
| 101 | Abnormality of salivation (HP:0100755) | 1.86678159 |
| 102 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.86527787 |
| 103 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.86517626 |
| 104 | Neuronal loss in central nervous system (HP:0002529) | 1.86109106 |
| 105 | Steppage gait (HP:0003376) | 1.85133068 |
| 106 | Inappropriate behavior (HP:0000719) | 1.84911779 |
| 107 | Clonus (HP:0002169) | 1.84098134 |
| 108 | Apathy (HP:0000741) | 1.83986644 |
| 109 | Hemiplegia (HP:0002301) | 1.83672835 |
| 110 | Diminished motivation (HP:0000745) | 1.83653394 |
| 111 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.82334784 |
| 112 | Distal sensory impairment (HP:0002936) | 1.82066506 |
| 113 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.81838836 |
| 114 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.81838836 |
| 115 | Psychosis (HP:0000709) | 1.81295840 |
| 116 | Autoamputation (HP:0001218) | 1.80787950 |
| 117 | Hyperthyroidism (HP:0000836) | 1.79079034 |
| 118 | Hypoplasia of the brainstem (HP:0002365) | 1.78008934 |
| 119 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.78008934 |
| 120 | Peripheral hypomyelination (HP:0007182) | 1.77887872 |
| 121 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.77510682 |
| 122 | Blue irides (HP:0000635) | 1.75481489 |
| 123 | Thickened helices (HP:0000391) | 1.75068911 |
| 124 | Hypoventilation (HP:0002791) | 1.74795680 |
| 125 | Ulnar claw (HP:0001178) | 1.72023747 |
| 126 | Bundle branch block (HP:0011710) | 1.71983424 |
| 127 | Exercise-induced muscle cramps (HP:0003710) | 1.71847791 |
| 128 | Heart block (HP:0012722) | 1.70132718 |
| 129 | Abnormality of the foot musculature (HP:0001436) | 1.69399902 |
| 130 | Paraplegia (HP:0010550) | 1.69269283 |
| 131 | Foot dorsiflexor weakness (HP:0009027) | 1.67417171 |
| 132 | Shoulder girdle muscle weakness (HP:0003547) | 1.66793032 |
| 133 | Sleep apnea (HP:0010535) | 1.66723668 |
| 134 | Spastic paraplegia (HP:0001258) | 1.66630282 |
| 135 | Spastic tetraplegia (HP:0002510) | 1.66382577 |
| 136 | Abnormal atrioventricular conduction (HP:0005150) | 1.65563742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.06401923 |
| 2 | NTRK3 | 4.03186574 |
| 3 | EPHA4 | 3.46329829 |
| 4 | MARK1 | 3.42638778 |
| 5 | MAP3K4 | 2.95591288 |
| 6 | MINK1 | 2.88333025 |
| 7 | KSR2 | 2.46817877 |
| 8 | NTRK1 | 2.42255714 |
| 9 | PAK6 | 2.37877251 |
| 10 | MAP2K7 | 2.37367706 |
| 11 | MAP3K12 | 2.31846994 |
| 12 | DAPK2 | 2.13053409 |
| 13 | MAP2K4 | 2.05776918 |
| 14 | TESK1 | 1.99823535 |
| 15 | RIPK4 | 1.98585200 |
| 16 | PNCK | 1.98379383 |
| 17 | NTRK2 | 1.90997843 |
| 18 | TRIM28 | 1.82698923 |
| 19 | KSR1 | 1.81840308 |
| 20 | PRKD3 | 1.78586910 |
| 21 | PLK2 | 1.56041278 |
| 22 | CAMKK1 | 1.53189806 |
| 23 | GRK5 | 1.52407757 |
| 24 | CDK5 | 1.51478470 |
| 25 | SIK3 | 1.51222781 |
| 26 | CASK | 1.50197183 |
| 27 | MAP3K2 | 1.48253021 |
| 28 | CDK19 | 1.45709860 |
| 29 | ARAF | 1.40523666 |
| 30 | LATS2 | 1.38863645 |
| 31 | UHMK1 | 1.24103132 |
| 32 | PHKG1 | 1.23368895 |
| 33 | PHKG2 | 1.23368895 |
| 34 | PDGFRA | 1.21719307 |
| 35 | MAPK13 | 1.20722191 |
| 36 | TYRO3 | 1.19888448 |
| 37 | DAPK1 | 1.19615516 |
| 38 | PAK3 | 1.17183183 |
| 39 | PRKCG | 1.12509673 |
| 40 | EPHA3 | 1.11500433 |
| 41 | LATS1 | 1.08048928 |
| 42 | CAMKK2 | 1.07587578 |
| 43 | STK24 | 1.07210777 |
| 44 | OXSR1 | 1.06430406 |
| 45 | CSNK1G2 | 1.04248870 |
| 46 | CDK14 | 1.03783216 |
| 47 | RET | 1.02967083 |
| 48 | MAP3K13 | 1.01618306 |
| 49 | STK38 | 1.00801523 |
| 50 | CAMK2A | 1.00361368 |
| 51 | SIK2 | 1.00332762 |
| 52 | RIPK1 | 0.96722236 |
| 53 | CDK18 | 0.95394347 |
| 54 | CDK15 | 0.93599218 |
| 55 | TNIK | 0.93475224 |
| 56 | CAMK2B | 0.87943904 |
| 57 | SCYL2 | 0.86264851 |
| 58 | STK39 | 0.84736062 |
| 59 | RAF1 | 0.82526970 |
| 60 | FES | 0.82108249 |
| 61 | CDK11A | 0.80936766 |
| 62 | PRPF4B | 0.79990698 |
| 63 | LMTK2 | 0.79040409 |
| 64 | STK11 | 0.78727742 |
| 65 | SGK223 | 0.78165053 |
| 66 | SGK494 | 0.78165053 |
| 67 | STK38L | 0.75063446 |
| 68 | PTK2B | 0.73696045 |
| 69 | FER | 0.73521890 |
| 70 | BMPR2 | 0.70951795 |
| 71 | DYRK1A | 0.69029379 |
| 72 | LIMK1 | 0.67782823 |
| 73 | PRKCH | 0.66253327 |
| 74 | MAP3K1 | 0.64949395 |
| 75 | CAMK1 | 0.64293678 |
| 76 | BCR | 0.64133290 |
| 77 | PTK2 | 0.63666605 |
| 78 | FGFR2 | 0.61819855 |
| 79 | WNK1 | 0.61745164 |
| 80 | PRKCE | 0.61612901 |
| 81 | MAPK12 | 0.61544787 |
| 82 | DYRK1B | 0.61395942 |
| 83 | CAMK2D | 0.59562102 |
| 84 | TAOK1 | 0.58596978 |
| 85 | FGR | 0.58170550 |
| 86 | MET | 0.57535297 |
| 87 | WNK4 | 0.57379907 |
| 88 | MAP2K1 | 0.57071971 |
| 89 | CSNK1G1 | 0.56693126 |
| 90 | SGK1 | 0.56093801 |
| 91 | MARK2 | 0.55438448 |
| 92 | PDPK1 | 0.54316381 |
| 93 | CAMK1G | 0.53948908 |
| 94 | PDK1 | 0.53770391 |
| 95 | PRKG2 | 0.53546449 |
| 96 | CAMK2G | 0.53224666 |
| 97 | PKN1 | 0.52707707 |
| 98 | PRKCZ | 0.52250864 |
| 99 | ALK | 0.52157192 |
| 100 | CSNK1G3 | 0.51360767 |
| 101 | EPHB2 | 0.51225523 |
| 102 | EPHB1 | 0.50854338 |
| 103 | ROCK2 | 0.50138473 |
| 104 | MAP3K6 | 0.49452232 |
| 105 | NME1 | 0.49324906 |
| 106 | PINK1 | 0.48367482 |
| 107 | MAPKAPK5 | 0.48154756 |
| 108 | MAP3K5 | 0.45790200 |
| 109 | YES1 | 0.45025740 |
| 110 | MAPK7 | 0.44873801 |
| 111 | DYRK2 | 0.44848619 |
| 112 | FYN | 0.44397374 |
| 113 | MAPK10 | 0.42843476 |
| 114 | PDGFRB | 0.41035974 |
| 115 | CAMK4 | 0.40341290 |
| 116 | RPS6KA4 | 0.40332661 |
| 117 | RPS6KA3 | 0.40184585 |
| 118 | NEK6 | 0.39905985 |
| 119 | SGK2 | 0.38902387 |
| 120 | CSNK1A1L | 0.36675958 |
| 121 | WNK3 | 0.35451902 |
| 122 | ERBB3 | 0.34690404 |
| 123 | SGK3 | 0.33023725 |
| 124 | DMPK | 0.32055632 |
| 125 | MOS | 0.31769704 |
| 126 | CCNB1 | 0.28528473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.28854344 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.20676482 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.63320696 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.55984835 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.55359039 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.51237591 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46449356 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.37607405 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.31226313 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.30052391 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.23765557 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16562106 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.04528231 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.93346147 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83523466 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81422993 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.78578286 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.71639493 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.70599617 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.68626341 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67757863 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66716242 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64058337 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60857692 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.59096392 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50870624 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.50646979 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47923167 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.40198872 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.36300271 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.36073043 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29887457 |
| 33 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.26102546 |
| 34 | Axon guidance_Homo sapiens_hsa04360 | 1.24758286 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.18497482 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17114818 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15491276 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.12976869 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12712995 |
| 40 | Melanogenesis_Homo sapiens_hsa04916 | 1.10324585 |
| 41 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08585856 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08096553 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05910654 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05287663 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05121203 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05056258 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04361705 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00630450 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.95426356 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95248213 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94096996 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93394057 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84631487 |
| 54 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83504312 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83494141 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82967964 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82100355 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81125015 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78596283 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76426699 |
| 61 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74835316 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.74768768 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73451443 |
| 64 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71944617 |
| 65 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71115713 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70695653 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70004710 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67548648 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67354688 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67318258 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67168320 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.66793849 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66706275 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66386163 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66057534 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65662196 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65234199 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63177351 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61979279 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60579817 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.56419123 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55770610 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.54674534 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53092127 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50314259 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50058607 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.48886568 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.48767339 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48626220 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48382040 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.48153436 |
| 92 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48123940 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47798294 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47443129 |
| 95 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46834997 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46454349 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46432159 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45442187 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45204562 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44809607 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.44759924 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44692919 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44410695 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44370570 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44125619 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.43643525 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43208323 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43110206 |
| 109 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41416133 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41296377 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.40260955 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39358081 |
| 113 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38706818 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38129827 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36141174 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35956635 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34846560 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34718850 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34643292 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34205053 |
| 121 | Tight junction_Homo sapiens_hsa04530 | 0.34022173 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32871538 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32023167 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30733324 |

